Furthermore, ardipusilloside I has been shown to reduce metastasis of HCC cells by activating Rac1, which results in upregulation of E-cadherin, subsequently leading to reduced metastatic capabilities. This evidence concerns the gene CDH1 and hepatocellular carcinoma.